Matches in SemOpenAlex for { <https://semopenalex.org/work/W3115994071> ?p ?o ?g. }
- W3115994071 endingPage "113" @default.
- W3115994071 startingPage "101" @default.
- W3115994071 abstract "Introduction: Neuroinflammation has been linked to poor neurologic and functional outcomes in many cerebrovascular disorders. Immune checkpoints are upregulated in the setting of traumatic brain injury, intracerebral hemorrhage, ischemic stroke, central nervous systems vasculitis, and post-hemorrhagic vasospasm, and are potential mediators of pathologic inflammation. Burgeoning evidence suggests that immune checkpoint modulation is a promising treatment strategy to decrease immune cell recruitment, cytokine secretion, brain edema, and neurodegeneration.Areas covered: This review discusses the role of immune checkpoints in neuroinflammation, and the potential for therapeutic immune checkpoint modulation in inflammatory cerebrovascular disorders. A search of Pubmed and clinicaltrials.gov was performed to find relevant literature published within the last 50 years.Expert opinion: The clinical success of immune-activating checkpoint modulators in human cancers has shown the immense clinical potential of checkpoint-based immunotherapy. Given that checkpoint blockade can also precipitate a pathologic pro-inflammatory or autoimmune response, it is plausible that these pathways may also be targeted to quell aberrant inflammation. A limited but growing number of studies suggest that immune checkpoints play a critical role in regulating the immune response in the central nervous system in a variety of contexts, and that immune-deactivating checkpoint modulators may be a promising treatment strategy for acute and chronic neuroinflammation in cerebrovascular disorders." @default.
- W3115994071 created "2021-01-05" @default.
- W3115994071 creator A5022191333 @default.
- W3115994071 creator A5071834319 @default.
- W3115994071 creator A5085331050 @default.
- W3115994071 date "2021-01-04" @default.
- W3115994071 modified "2023-10-18" @default.
- W3115994071 title "The potential for immune checkpoint modulators in cerebrovascular injury and inflammation" @default.
- W3115994071 cites W128151115 @default.
- W3115994071 cites W1497879842 @default.
- W3115994071 cites W1519171461 @default.
- W3115994071 cites W1588685142 @default.
- W3115994071 cites W1588726805 @default.
- W3115994071 cites W1840847833 @default.
- W3115994071 cites W185304927 @default.
- W3115994071 cites W1898345095 @default.
- W3115994071 cites W1972400577 @default.
- W3115994071 cites W1973338533 @default.
- W3115994071 cites W1973744968 @default.
- W3115994071 cites W1982694435 @default.
- W3115994071 cites W1983123363 @default.
- W3115994071 cites W1985085315 @default.
- W3115994071 cites W1985997449 @default.
- W3115994071 cites W1988100193 @default.
- W3115994071 cites W1989138409 @default.
- W3115994071 cites W1991597061 @default.
- W3115994071 cites W1994215186 @default.
- W3115994071 cites W1997731331 @default.
- W3115994071 cites W1999235115 @default.
- W3115994071 cites W1999645052 @default.
- W3115994071 cites W2000351290 @default.
- W3115994071 cites W2001244796 @default.
- W3115994071 cites W2001997798 @default.
- W3115994071 cites W2002842060 @default.
- W3115994071 cites W2003890250 @default.
- W3115994071 cites W2005158904 @default.
- W3115994071 cites W2006925820 @default.
- W3115994071 cites W2007890844 @default.
- W3115994071 cites W2009178440 @default.
- W3115994071 cites W2009766925 @default.
- W3115994071 cites W2010068120 @default.
- W3115994071 cites W2012992125 @default.
- W3115994071 cites W2014372297 @default.
- W3115994071 cites W2014541497 @default.
- W3115994071 cites W2015693978 @default.
- W3115994071 cites W2018683277 @default.
- W3115994071 cites W2027913805 @default.
- W3115994071 cites W2028376975 @default.
- W3115994071 cites W2030259456 @default.
- W3115994071 cites W2034650743 @default.
- W3115994071 cites W2035221144 @default.
- W3115994071 cites W2036451329 @default.
- W3115994071 cites W2036962028 @default.
- W3115994071 cites W2040216480 @default.
- W3115994071 cites W2041363468 @default.
- W3115994071 cites W2043020388 @default.
- W3115994071 cites W2045683532 @default.
- W3115994071 cites W2052675579 @default.
- W3115994071 cites W2056034889 @default.
- W3115994071 cites W2057154892 @default.
- W3115994071 cites W2057831907 @default.
- W3115994071 cites W2061071534 @default.
- W3115994071 cites W2063429181 @default.
- W3115994071 cites W2066671159 @default.
- W3115994071 cites W2066797341 @default.
- W3115994071 cites W2068050062 @default.
- W3115994071 cites W2069986717 @default.
- W3115994071 cites W2072364378 @default.
- W3115994071 cites W2075819066 @default.
- W3115994071 cites W2084430660 @default.
- W3115994071 cites W2091609575 @default.
- W3115994071 cites W2092861594 @default.
- W3115994071 cites W2095692889 @default.
- W3115994071 cites W2096019298 @default.
- W3115994071 cites W2097756768 @default.
- W3115994071 cites W2099560139 @default.
- W3115994071 cites W2101898118 @default.
- W3115994071 cites W2102182787 @default.
- W3115994071 cites W2104287195 @default.
- W3115994071 cites W2105272176 @default.
- W3115994071 cites W2107475094 @default.
- W3115994071 cites W2114684229 @default.
- W3115994071 cites W2121080034 @default.
- W3115994071 cites W2123301364 @default.
- W3115994071 cites W2128063282 @default.
- W3115994071 cites W2130822830 @default.
- W3115994071 cites W2132489910 @default.
- W3115994071 cites W2132862382 @default.
- W3115994071 cites W2132962150 @default.
- W3115994071 cites W2133428572 @default.
- W3115994071 cites W2133577718 @default.
- W3115994071 cites W2133909309 @default.
- W3115994071 cites W2136662085 @default.
- W3115994071 cites W2137368645 @default.
- W3115994071 cites W2139076163 @default.
- W3115994071 cites W2139262607 @default.
- W3115994071 cites W2139737765 @default.
- W3115994071 cites W2141026681 @default.